Cited by 139TGF-β signaling in diseasesBlood Coagulation and Thrombosis MechanismsPlatelet Disorders and Treatments

The DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.

Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β

Open access

Metelli, Alessandra, Wu, Bill X., Riesenberg, Brian, Guglietta, Silvia, Huck, John D., Mills, Catherine, Li, Anqi, Rachidi, Saleh, Krieg, Carsten, Rubinstein, Mark P., Gewirth, Daniel T., Sun, Shaoli, Lilly, Michael B., Wahlquist, Amy H., Carbone, David P., Yang, Yiping, Liu, Bei, Li, Zihai·2020·Science Translational Medicine

DOI 10.1126/scitranslmed.aay4860PMC PMC7814995

Open this paper in CoChat — free account

Abstract

Proteolysis of platelet-bound GARP by thrombin liberates active TGF-β and contributes to cancer immune evasion in the tumor microenvironment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.aay4860

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 27,235
SWISS-MODEL: homology modelling of protein structures and complexes
Waterhouse, A. M., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T., Rempfer, C., Bordoli, L., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky427 · Cited by 13,248
FlowSOM: Using self‐organizing maps for visualization and interpretation of cytometry data
Gassen, S. V., Callebaut, B., van Helden, M. J. G., Lambrecht, B. N., Demeester, P. M. A., Dhaene, T., & Saeys, Y. (2015) · Cytometry Part A · doi:10.1002/cyto.a.22625 · Cited by 1,930
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
Tauriello, D. V. F., Palomo-Ponce, S., Stork, D., Berenguer-Llergo, A., Badia-Ramentol, J., Iglesias, M., Sevillano, M., Ibiza, S., Cañellas, A., Hernando-Momblona, X., et al. (2018) · Nature · doi:10.1038/nature25492 · Cited by 1,851
Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
Shevach, E. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.010 · Cited by 1,787
TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
Thomas, D. A., & Massagué, J. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.012 · Cited by 1,355
Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism.
Bhowmick, N., Ghiassi, M., Bakin, A. V., Aakre, M., Lundquist, C., Engel, M., Arteaga, C., & Moses, H. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.1.27 · Cited by 1,087
Latent TGF-β structure and activation
Shi, M., Zhu, J., Wang, R., Chen, X., Mi, L., Walz, T., & Springer, T. A. (2011) · Nature · doi:10.1038/nature10152 · Cited by 1,013
The roles of TGFβ in the tumour microenvironment
Pickup, M. W., Novitskiy, S. V., & Moses, H. L. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3603 · Cited by 936
Overview of the coagulation system
Palta, S., Saroa, R., & Palta, A. (2014) · Indian Journal of Anaesthesia · doi:10.4103/0019-5049.144643 · Cited by 903

Show all 68 references

Research works printed but not linked: 1

10.12688/f1000research.11622.1 · DOI

Sorted by citations

TGFβ biology in cancer progression and immunotherapy
Derynck, R., Turley, S. J., & Akhurst, R. J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0403-1 · Cited by 944
Combination strategies to maximize the benefits of cancer immunotherapy
Zhu, S., Zhang, T., Zheng, L., Liu, H., Song, W., Liu, D., Li, Z., & Pan, C.-X. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01164-5 · Cited by 654
Self-citation
Overcoming TGFβ-mediated immune evasion in cancer
Tauriello, D. V. F., Sancho, E., & Batlle, E. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00413-6 · Cited by 377
TGF ‐β as a driver of fibrosis: physiological roles and therapeutic opportunities
Budi, E. H., Schaub, J. R., Decaris, M. L., Turner, S., & Derynck, R. (2021) · The Journal of Pathology · doi:10.1002/path.5680 · Cited by 310
TGF-β Regulation of T Cells
Chen, W. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101921-045939 · Cited by 299
Transforming growth factor–β1 in regulatory T cell biology
Moreau, J. M., Velegraki, M., Bolyard, C. M., Rosenblum, M. D., & Li, Z. (2022) · Science Immunology · doi:10.1126/sciimmunol.abi4613 · Cited by 260
Self-citation
The dynamic role of platelets in cancer progression and their therapeutic implications
Li, S., Lu, Z., Wu, S., Chu, T., Li, B., Qi, F., Zhao, Y., & Nie, G. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00639-6 · Cited by 226
Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer
Hinterleitner, C., Strähle, J., Malenke, E., Hinterleitner, M., Henning, M., Seehawer, M., Bilich, T., Heitmann, J., Lutz, M., Mattern, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27303-7 · Cited by 175
TGF-beta signal transduction: biology, function and therapy for diseases
Tie, Y., Tang, F., Peng, D., Zhang, Y., & Shi, H. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00109-9 · Cited by 186
TGF-β, EMT, and resistance to anti-cancer treatment
Wang, X., Eichhorn, P. J. A., & Thiery, J. P. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.10.004 · Cited by 187
Analyzing high-dimensional cytometry data using FlowSOM
Quintelier, K. L. A., Couckuyt, A., Emmaneel, A., Aerts, J. G. J. V., Saeys, Y., & Gassen, S. V. (2021) · Nature Protocols · doi:10.1038/s41596-021-00550-0 · Cited by 178
Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer
de Streel, G., Bertrand, C., Chalon, N., Liénart, S., Bricard, O., Lecomte, S., Devreux, J., Gaignage, M., Boeck, G. D., Mariën, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17811-3 · Cited by 151
Platelet-Cancer Interplay: Molecular Mechanisms and New Therapeutic Avenues
Braun, A., Anders, H., Gudermann, T. W., & Mammadova‐Bach, E. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.665534 · Cited by 122
Coagulome and the tumor microenvironment: an actionable interplay
Galmiche, A., Rak, J., Roumenina, L. T., & Saidak, Z. (2022) · Trends in cancer · doi:10.1016/j.trecan.2021.12.008 · Cited by 111
Interplay between coagulation and inflammation in cancer: Limitations and therapeutic opportunities
Bauer, A. T., Gorzelanny, C., Gebhardt, C., Pantel, K., & Schneider, S. W. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102322 · Cited by 94
Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression
van den Bulk, J., de Miranda, N. F. C. C., & ten Dijke, P. (2021) · Clinical Science · doi:10.1042/cs20201236 · Cited by 78
Fucoidan-functionalized activated platelet-hitchhiking micelles simultaneously track tumor cells and remodel the immunosuppressive microenvironment for efficient metastatic cancer treatment
Guo, R., Deng, M., He, X., Li, M., Li, J., He, P., Liu, H., Li, M., Zhang, Z., & He, Q. S. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.012 · Cited by 74
Exhaust the exhausters: Targeting regulatory T cells in the tumor microenvironment
McRitchie, B., & Akkaya, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940052 · Cited by 79
Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence
Kreatsoulas, D. C., Bolyard, C. M., Wu, B. X., Çam, H., Giglio, P., & Li, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01298-0 · Cited by 75
Self-citation
Anticoagulation with Factor Xa Inhibitors Is Associated with Improved Overall Response and Progression-Free Survival in Patients with Metastatic Malignant Melanoma Receiving Immune Checkpoint Inhibitors—A Retrospective, Real-World Cohort Study
Haist, M., Stege, H. M., Pemler, S., Heinz, J., Fleischer, M. I., Graf, C., Ruf, W., Loquai, C., & Grabbe, S. (2021) · Cancers · doi:10.3390/cancers13205103 · Cited by 58
Functional visualization of NK cell-mediated killing of metastatic single tumor cells
Ichise, H., Tsukamoto, S., Hirashima, T., Konishi, Y., Oki, C., Tsukiji, S., Iwano, S., Miyawaki, A., Sumiyama, K., Terai, K., et al. (2022) · eLife · doi:10.7554/elife.76269 · Cited by 58
Combining flavin photocatalysis with parallel synthesis: a general platform to optimize peptides with non-proteinogenic amino acids
Immel, J. R., Chilamari, M., & Bloom, S. H. (2021) · Chemical Science · doi:10.1039/d1sc02562g · Cited by 57
Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective
Danielpour, D. (2024) · Pharmaceuticals · doi:10.3390/ph17040533 · Cited by 58
Tumor educated platelet: the novel BioSource for cancer detection
Ding, S., Dong, X., & Song, X. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02927-5 · Cited by 53
Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia
Wang, L., Wang, H., Zhu, M., Ni, X., Sun, L., Wang, W., Xie, J., Li, Y., Xu, Y., Wang, R., et al. (2024) · Blood · doi:10.1182/blood.2023022738 · Cited by 46
The Effect of Systemic Immune-Inflammatory Index (SII) and Prognostic Nutritional Index (PNI) in Early Gastric Cancer
Jing, Y., Ren, M., Li, X., Sun, X., Xiao, Y., Xue, J., & Liu, Z. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s499094 · Cited by 42
Interactions between Platelets and Tumor Microenvironment Components in Ovarian Cancer and Their Implications for Treatment and Clinical Outcomes
Öncül, S., & Cho, M. S. (2023) · Cancers · doi:10.3390/cancers15041282 · Cited by 41
The role of coagulome in the tumor immune microenvironment
Wahab, R., Hasan, M. M., Azam, Z., Grippo, P. J., & Al-Hilal, T. A. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115027 · Cited by 43
Perfluorotributylamine-Loaded Albumin Nanoparticles Downregulate Platelet-Derived TGFβ to Inhibit Tumor Metastasis
Luo, L., Zhang, B., Tao, F., Chen, Z., Ye, Q., Zhao, X., & Wu, J. (2023) · ACS Nano · doi:10.1021/acsnano.3c00295 · Cited by 38
Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8 + T cell antitumor immunity
Li, A., Chang, Y., Song, N., Wu, X., Chung, D., Riesenberg, B., Velegraki, M., Giuliani, G. D., Das, K., Okimoto, T., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005433 · Cited by 32
Self-citation
Pro-inflammatory megakaryocyte gene expression in murine models of breast cancer
Roweth, H. G., Malloy, M. W., Goreczny, G. J., Becker, I. C., Guo, Q., Mittendorf, E. A., Italiano, J. E., McAllister, S. S., & Battinelli, E. M. (2022) · Science Advances · doi:10.1126/sciadv.abo5224 · Cited by 32
Overcoming Stromal Barriers to Immuno-Oncological Responses via Fibroblast Activation Protein-Targeted Therapy
Brennen, W. N., Thorek, D. L. J., Jiang, W., Krueger, T. E. G., Antony, L., Denmeade, S. R., & Isaacs, J. T. (2020) · Immunotherapy · doi:10.2217/imt-2020-0066 · Cited by 33
Immunomodulatory role of thrombin in cancer progression
Alexander, E. T., & Gilmour, S. K. (2022) · Molecular Carcinogenesis · doi:10.1002/mc.23398 · Cited by 32
Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies
Lutz, M. S., Klimovich, B., Maurer, S., Heitmann, J. S., Märklin, M., Zekri, L., Jung, G., Salih, H. R., & Hinterleitner, C. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003655 · Cited by 31
Platelets in the tumor microenvironment and their biological effects on cancer hallmarks
Chen, L., Zhu, C., Pan, F., Chen, Y., Xiong, L., Li, Y., Chu, X., & Huang, G. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1121401 · Cited by 37
Platelet-Derived GARP Induces Peripheral Regulatory T Cells—Potential Impact on T Cell Suppression in Patients with Melanoma-Associated Thrombocytosis
Zimmer, N., Krebs, F. K., Zimmer, S., Mitzel-Rink, H., Kumm, E. J., Jurk, K., Grabbe, S., Loquai, C., & Tuettenberg, A. (2020) · Cancers · doi:10.3390/cancers12123653 · Cited by 30
Soluble immune checkpoint molecules in cancer risk, outcomes prediction, and therapeutic applications
Chen, L., Chao, Y., Li, W., Wu, Z., & Wang, Q. (2024) · Biomarker Research · doi:10.1186/s40364-024-00647-0 · Cited by 29
Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy
Shafqat, A., Omer, M. H., Ahmed, E. N., Mushtaq, A. H., Ijaz, E., Ahmed, Z., AlKattan, K. M., & Yaqinuddin, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1200941 · Cited by 32
GARP as a Therapeutic Target for the Modulation of Regulatory T Cells in Cancer and Autoimmunity
Zimmer, N., Trzeciak, E. R., Graefen, B., Satoh, K., & Tuettenberg, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.928450 · Cited by 26
The Complex Role of Thrombin in Cancer and Metastasis: Focus on Interactions with the Immune System
Aleksandrowicz, K., Hempel, D., Polityńska, B., Wojtukiewicz, A. M., Honn, K. V., Tang, D. G., & Wojtukiewicz, M. Z. (2023) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0043-1776875 · Cited by 26
Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients
Johannet, P. M., Sawyers, A., Gulati, N., Donnelly, D. M., Kozloff, S., Qian, Y., Floristán, A., Hernando, E., Zhong, J., & Osman, I. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02712-w · Cited by 25
RETRACTED: Coagulation and inflammation in cancer: Limitations and prospects for treatment
Singh, A. K., & Malviya, R. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188727 · Cited by 26
Retracted
Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosis
Lecomte, S., Devreux, J., de Streel, G., van Baren, N., Havelange, V., Schröder, D., Vaherto, N., Vanhaver, C., Vanderaa, C., Dupuis, N., et al. (2022) · Blood · doi:10.1182/blood.2022017097 · Cited by 27
Protein Corona Gold Nanoparticles Fingerprinting Reveals a Profile of Blood Coagulation Proteins in the Serum of HER2-Overexpressing Breast Cancer Patients
Chantada‐Vázquez, M. D. P., López, A. C., García-Vence, M., Nebril, B. A., Bravo, S. B., & Núñez, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228449 · Cited by 24
Precise fibrin decomposition and tumor mechanics modulation with hydroxyethyl starch-based smart nanomedicine for enhanced antitumor efficacy
Chen, J., Zhang, Z., Li, Y., Zeng, H., Li, Z., Wang, C., Chen, X., Deng, Q., Wang, Q., Yang, X., et al. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb01812h · Cited by 23
Self-citation
Biodegradable electrospun nanofibrous platform integrating antiplatelet therapy-chemotherapy for preventing postoperative tumor recurrence and metastasis
Li, J., Li, J., Yao, Y., Yong, T., Bie, N., Wei, Z., Li, X., Li, S., Qin, J., Jia, H., et al. (2022) · Theranostics · doi:10.7150/thno.69795 · Cited by 22
Interactions between platelets and the cancer immune microenvironment
Tuerhong, N., Yang, Y., Wang, C., Huang, P., & Li, Q. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104380 · Cited by 21
Self-citation
Systemic inflammation is associated with inferior disease control and survival in stage III non-small cell lung cancer
Keit, E., Coutu, B. G., Zhen, W. K., Zhang, C., Lin, C., Bennion, N. R., Ganti, A. K., Ernani, V., & Baine, M. J. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-6710 · Cited by 21
Interplay of stromal tumor-infiltrating lymphocytes, normal colonic mucosa, cancer-associated fibroblasts, clinicopathological data and the immunoregulatory molecules of patients diagnosed with colorectal cancer
Zadka, Ł., Chabowski, M., Grybowski, D. J., Piotrowska, A., & Dzięgiel, P. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02863-1 · Cited by 21
Platelets in cancer and immunotherapy: functional dynamics and therapeutic opportunities
Cai, C., Liu, Y., Lu, R., Fan, X., Zeng, S., & Gan, P. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00676-x · Cited by 23
Concomitant Medication Effects on Immune Checkpoint Inhibitor Efficacy and Toxicity
Sieber, B., Strauss, J., Li, Z., & Gatti-Mays, M. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.836934 · Cited by 19
Self-citation
Engineering Cell‐Based Systems for Smart Cancer Therapy
Mirkhani, N., Gwisai, T., & Schuerle, S. (2021) · Advanced Intelligent Systems · doi:10.1002/aisy.202100134 · Cited by 17
Exploitation of platelets for antitumor drug delivery and modulation of the tumor immune microenvironment
Guo, J., Wang, M., Zhu, Y., Watari, F., Xu, Y.-H., & Chen, X. (2023) · Acta Materia Medica · doi:10.15212/amm-2023-0005 · Cited by 18
Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy – A multicenter study on 2419 patients from the prospective skin cancer registry ADOReg
Kött, J., Zell, T., Zimmermann, N., Rünger, A., Smit, D. J., Abeck, F., Geidel, G., Hansen, I., Heidrich, I., Weichenthal, M., et al. (2024) · European Journal of Cancer · doi:10.1016/j.ejca.2024.115159 · Cited by 17
Platelets for advanced drug delivery in cancer
Cacic, D. L., Hervig, T. A., & Reikvam, H. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2217378 · Cited by 17
GARP: A Key Target to Evaluate Tumor Immunosuppressive Microenvironment
Bouchard, A., Collin, B., Garrido, C., Bellaye, P., & Kohli, É. (2021) · Biology · doi:10.3390/biology10090836 · Cited by 16
Artificial Intelligence–Powered Hematoxylin and Eosin Analyzer Reveals Distinct Immunologic and Mutational Profiles among Immune Phenotypes in Non–Small-Cell Lung Cancer
Park, J., Cho, H.-G., Park, J., Lee, G., Kim, H. S., Paeng, K., Song, S., Park, G., Ock, C., & Chae, Y. K. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.01.006 · Cited by 16
Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling
Turi, M., Sithara, A. A., Hofmanová, L., Žihala, D., Radhakrishnan, D., Vdovin, A., Knápková, S., Ševčíková, T., Chyra, Z., Jelı́nek, T., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065623 · Cited by 15
Coagulation Protease-Driven Cancer Immune Evasion: Potential Targets for Cancer Immunotherapy
Paul, S., Mukherjee, T., & Das, K. (2024) · Cancers · doi:10.3390/cancers16081568 · Cited by 16
Single‐Domain Antibody‐Based TCR‐Like CAR‐T: A Potential Cancer Therapy
Zhu, L., Yang, X., Zhong, D., Xie, S., Shi, W., Li, Y., Hou, X., HuaYao, Zhou, H., Zhao, M., et al. (2020) · Journal of Immunology Research · doi:10.1155/2020/2454907 · Cited by 14
Decoding the role of platelets in tumour metastasis: enigmatic accomplices and intricate targets for anticancer treatments
Zhao, J., Huang, A., Zeller, J., Peter, K., & McFadyen, J. D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1256129 · Cited by 14
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy
Li, M., Zhao, S., Lopez, G., Secor, A., Das, P., Surya, N., Grogan, M. M., Patel, S. H., Chakravarthy, K., Miah, A., et al. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03392-9 · Cited by 13
Self-citation
mTOR Promotes Tissue Factor Expression and Activity in EGFR-Mutant Cancer
Cong, Y., Li, Q., Zhang, X., Chen, Y., & Yu, K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01615 · Cited by 14
Large-Scale Transcriptome Data Analysis Identifies KIF2C as a Potential Therapeutic Target Associated With Immune Infiltration in Prostate Cancer
Zhang, P., Gao, H., Ye, C., Yan, R., Yu, L., Xia, C., & Yang, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.905259 · Cited by 13
Cancer progression and tumor hypercoagulability: a platelet perspective
Zhang, Y., Zeng, J., Bao, S., Zhang, B., Li, X., Wang, H., Cheng, Y., Zhang, H., Zu, L., Xu, X. N., et al. (2024) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-024-02993-0 · Cited by 12
O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer
Martínez, I. P. V., Pérez‐Campos, E., Mayoral, L. P.-C., Cruz-Luis, H., Pina-Canseco, M. D. S., Zenteno, E., Salinas, I. L. B., Cruz, M. M., Mayoral, E. P., & Hernández‐Huerta, M. T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189896 · Cited by 11
Circulating Proteins Associated with Response and Resistance to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer
Chantada‐Vázquez, M. D. P., Conde‐Amboage, M., Graña-López, L., Vázquez‐Estévez, S., Bravo, S. B., & Núñez, C. (2022) · Cancers · doi:10.3390/cancers14041087 · Cited by 11
Unlocking the intricacies: Exploring the complex interplay between platelets and ovarian cancer
Xie, Q., Zhou, J., He, C., Xu, Y., Tao, F., & Hu, M. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104465 · Cited by 10
Bioengineering Platelets Presenting PD‐L1, Galectin‐9 and BTLA to Ameliorate Type 1 Diabetes
Ma, Y., Meng, F., Lin, Z., Chen, Y., Lan, T., Yang, Z., Diao, R., Zhang, X., Chen, Q., Zhang, C., et al. (2025) · Advanced Science · doi:10.1002/advs.202501139 · Cited by 13
Precision immunotherapy for head and neck cancer: therapeutic combinations, biomarker strategies, and translational challenges
Okuyama, K., Naruse, T., Matsushita, Y., Fujimoto, J., Yanamoto, S., Lei, Y. L., & Hu, J. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02609-6 · Cited by 9
Prognostic Value of Platelet Distribution Width and Mean Platelet Volume in Patients with Laryngeal Cancer
Guo, E., Zhang, C., Guo, L., Song, K., Wang, G., Duan, C., Yang, X., Yuan, Z., Guo, J., Sun, J., et al. (2021) · Future Oncology · doi:10.2217/fon-2020-0658 · Cited by 9
Relationship between tumorigenesis, metastasis, immune evasion, and chemoresistance in osteosarcoma therapy
Lim, Y. Y., Zaidi, A. M. A., Haque, M., & Miskon, A. (2023) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2023.149907 · Cited by 9
Reversibly size-switchable polyion complex micelles for antiangiogenic cancer therapy
Sun, M., Zhou, M., Xiao, Y., Tang, H., Chen, J.-H., Zhang, R., Li, C., Ya, Q., Chen, Q., Tu, J., et al. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.109110 · Cited by 7
Coagulation-Targeted TGF-β Signaling Pathway Inhibitor Nanomedicine for Inhibiting the Growth and Lung Metastasis of Breast Cancer
Xu, Y., Lv, J., Liu, Y., Du, J., Luo, C., Wang, Y., Liu, L., Sakurai, K., Tang, Z., & Chen, X. (2024) · Nano Letters · doi:10.1021/acs.nanolett.4c05355 · Cited by 7
Unveiling the “Dark Matter” of platelet involvement in tumor microenvironment
Zhang, P., Zu, R., Zhang, X., Ren, H., Rao, L., Wang, D., Li, T. X., Leng, P., & Luo, H. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101218 · Cited by 7
A biomaterial-based platform of pancreatic cancer reveals kallikrein-related peptidase 6 (KLK6) as a mediator of neutrophil recruitment and immunosuppression
Kast, V., Hauser, S., Nadernezhad, A., Pette, D., Maitz, M. F., Petzold, A., Dahl, A., Seifert, M., Eubler, K., Mayerhofer, A., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123456 · Cited by 7
Key platelet genes play important roles in predicting the prognosis of sepsis
Shen, L., Tao, C., Zhu, K., Cai, L., Yang, S., Jin, J., Ren, Y., Xiao, Y., Zhang, Y., Lai, D., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-74052-w · Cited by 7
Transforming Growth Factors in Venous Thrombus Formation and Resolution
Davis, J., Maranto, M., Kennedy, J., Wang, X., Azhar, M., Jain, A., & Evans, C. E. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.322395 · Cited by 8
FVIIa-PAR2 signaling facilitates immune escape by reducing phagocytic potential of macrophages in breast cancer
Ghosh, A., Bhoumick, A., Paul, S., Chatterjee, A., Mandal, S., Basu, A., Mukhopadhyay, S., Das, K., & Sen, P. (2024) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2024.11.027 · Cited by 6
Adjuvant chemotherapy for lymph node positive esophageal squamous cell cancer: The prediction role of low mean platelet volume
Liu, X., Zhang, K., Jie, T., Li, J., Jiang, Y., & Wang, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1067682 · Cited by 6
Tumor-educated platelets as liquid biopsy: Uncovering the mechanisms of cancer progression
Schmidl, B., Wei, K., Ghasemimehr, N., Dezfouli, A. B., & Wollenberg, B. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.105106 · Cited by 5
Tumor-platelet cross talk in cancer: mechanisms, thrombotic risk, and translational opportunities
dos Santos, B. G., Li, Z., & Barrett, T. J. (2026) · Blood Advances · doi:10.1182/bloodadvances.2026019991 · Cited by 5
Self-citation
A novel immune-related gene signature for diagnosis and potential immunotherapy of microsatellite stable endometrial carcinoma
Xiao, Y., Yu, X., Wang, Y., Song, G., Liu, M. R., Wang, D., & Wang, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-53338-z · Cited by 5
Integrative Quantitative Analysis of Platelet Proteome and Site-Specific Glycoproteome Reveals Diagnostic Potential of Platelet Glycoproteins for Liver Cancer
Xie, X., Xiang, J., Zhao, H., Tong, B., Zhang, L., Kang, X., Kong, S., Wang, T., & Cao, W. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c03855 · Cited by 5
An artificial-enzyme-equipped immunoregulator blocks platelet-mediated breast cancer hematogenous metastasis
Hu, B., Lin, H., Quan, X., Sun, F., Zhang, F., Zhang, F., Wang, Y., Chang, Y., Wang, J., Duan, X., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123380 · Cited by 5
GARP Regulates the Immune Capacity of a Human Autologous Platelet Concentrate
Trzeciak, E. R., Zimmer, N., Kämmerer, P. W., Thiem, D. G. E., Al‐Nawas, B., Tuettenberg, A., & Blatt, S. (2022) · Biomedicines · doi:10.3390/biomedicines10123136 · Cited by 5
Tregs and Platelets Play Synergistic Roles in Tumor Immune Escape and Inflammatory Diseases
Gao, H., Zhou, Y., & Chen, X. (2022) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2023047234 · Cited by 7
Lentinan Alleviated PM2.5 Exposure-Induced Epithelial–Mesenchymal Transition in Pulmonary Epithelial Cells by Inhibiting the GARP/TGF-β/Smad Pathway
Wang, Z., Xu, S., Bian, B., Hu, Z., Wu, F., Zhao, S., Wang, X., Wang, L., & Ma, T. (2025) · Toxics · doi:10.3390/toxics13030166 · Cited by 4
Coagulation proteases modulate nucleic acid uptake and cGAS-STING-IFN induction in the tumor microenvironment
Wilgenbus, P., Pott, J., Pagel, S., Witzler, C., Royce, J., Marini, F., Reyda, S., Madhusudhan, T., Kindler, T., Hausen, A., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.190311 · Cited by 6
TGFβ enhances platelet–breast‐cancer‐cell interaction and promotes platelet aggregation
Genitoni, M., Merolle, L., Razzoli, A., Maurizi, E., Gavioli, G., Baricchi, R., Marraccini, C., & Schiroli, D. (2025) · FEBS Journal · doi:10.1111/febs.70279 · Cited by 4
Drug-drug interactions in anticoagulant therapy: a focus on oncology patients
Vrotniakaite-Bajerciene, K., Tsang, C., Wang, T., & Carrier, M. (2025) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2025.2585448 · Cited by 4
Platelets in the tumor microenvironment: potential mediators of immune exclusion and resistance to immune checkpoint inhibitor therapy
Kansestani, A. N., Zare, M. E., & Zhang, J. (2026) · Cellular Oncology · doi:10.1007/s13402-025-01129-7 · Cited by 4
Synergistic effects of anticoagulants and platelet aggregation inhibitors with immune checkpoint inhibitors in cancer therapy: a comprehensive review of preclinical and clinical evidence
Kött, J., Matthes, N., Bauer, A. T., Zimmermann, N., Zell, T., Smit, D. J., Schneider, S. W., & Gebhardt, C. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-013879 · Cited by 4
Characterization of Platelet Function-Related Gene Predicting Survival and Immunotherapy Efficacy in Gastric Cancer
Xia, Y., Lin, X., Cheng, Y., Xu, H., Zeng, J., Xie, W., Wang, M., & Sun, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.938796 · Cited by 4
Small but mighty: Platelets as multifunctional architects of tumor metastasis and immune regulation
Tang, L., Shi, H., & Luo, Y. (2024) · MedComm – Future Medicine · doi:10.1002/mef2.70000 · Cited by 4
New insight into GARP striking role in cancer progression: application for cancer therapy
Lahimchi, M. R., Eslami, M., & Yousefi, B. (2022) · Medical Oncology · doi:10.1007/s12032-022-01881-y · Cited by 4
ADNP is associated with immune infiltration and radiosensitivity in hepatocellular carcinoma for predicting the prognosis
Wang, X., Peng, H., Zhang, G., Li, Z., Du, Z., Peng, B., & Cao, P. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01592-x · Cited by 4
Self-citation
Associations Between Immune-Related Venous Thromboembolism and Efficacy of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
Li, H., Li, H., Tang, L., Niu, H., He, L., & Luo, Q. (2023) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296231206799 · Cited by 4
Anticoagulation for the treatment of immune checkpoint inhibitor–associated venous thromboembolism
Chiang, C., Osataphan, S. A., Chang, Y., Chi, K., Chiang, C., Chang, Y., & Patell, R. D. (2024) · Blood Advances · doi:10.1182/bloodadvances.2024013869 · Cited by 3
Spatial Distribution of Non-Immune Cells Expressing Glycoprotein A Repetitions Predominant in Human and Murine Metastatic Lymph Nodes
Rouaud, L., Baudin, L., Gautier‐Isola, M., Meerbeeck, P. V., Feyereisen, É., Blacher, S., van Baren, N., Kridelka, F., Lucas, S., & Noël, A. (2023) · Cancers · doi:10.3390/cancers15235621 · Cited by 3

Authors: Metelli, A., Wu, B. X., Riesenberg, B., Guglietta, S., Huck, J. D., Mills, C., Li, A., Rachidi, S., Krieg, C., Rubinstein, M. P., Gewirth, D. T., Sun, S., Lilly, M. B., Wahlquist, A. H., Carbone, D. P., Yang, Y., Liu, B., & Li, Z.
Affiliations: Medical University of South Carolina (US)
Pelotonia (US)
Hauptman-Woodward Medical Research Institute (US)
Corresponding author: Li, Zihai
ORCID: Metelli, Alessandra
Wu, Bill X.
Riesenberg, Brian
Guglietta, Silvia
Huck, John D.
Mills, Catherine
Li, Anqi
Rachidi, Saleh
Krieg, Carsten
Rubinstein, Mark P.
Gewirth, Daniel T.
Lilly, Michael B.
Carbone, David P.
Yang, Yiping
Liu, Bei
Li, Zihai
Venue: Science Translational Medicine
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2020-01-08
Volume: 12
Issue: 525
ISSN: 1946-6234 (ISSN-L)
1946-6242
DOI: 10.1126/scitranslmed.aay4860
PMC: PMC7814995
OpenAlex: W3000560268
Cited by: 139
References: 68
Citations by year: 2026: 21 · 2025: 22 · 2024: 20 · 2023: 26 · 2022: 24 · 2021: 19 · 2020: 7
FWCI: 6.16
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Science Translational Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (P01CA186866)
National Institute of Allergy and Infectious Diseases (R01AI077283)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
Keywords: thrombin, tumor immune evasion, GARP, latent TGF-beta1, platelets, proteolysis, tumor microenvironment, antitumor immunity, PD-1 immune checkpoint blockade, circulating biomarkers, thrombin inhibition
MeSH terms: Immune Checkpoint Inhibitors, Animals, Blood Platelets, Cell Membrane, Humans, Membrane Proteins, Mice, Inbred BALB C, Mice, Inbred C57BL, Neoplasms, Protein Binding, Thrombin, Disease Progression, Latent TGF-beta Binding Proteins, Immune Evasion, Tumor Microenvironment, Proteolysis, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks